Celldex Therapeutics buy Morgan Stanley
Start price
07.08.26
/
50%
€36.10
Target price
07.08.27
€39.92
Performance (%)
0.00%
Price
06.08.26
€35.00
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley is currently unchanged from the start price. This prediction currently runs until 07.08.27. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Celldex Therapeutics | 0.00% |
| iShares Core DAX® | 2.573% |
| iShares Nasdaq 100 | 4.858% |
| iShares Nikkei 225® | 5.590% |
| iShares S&P 500 | 3.250% |
Comments by Morgan_Stanley for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (CLDX) had its price target raised by Morgan Stanley from $40.00 to $46.00. They now have an "overweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Morgan_Stanley for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€30.47
22.07.26
22.07.26
€35.07
22.07.27
22.07.27
18.48%
06.08.26
06.08.26
Celldex Therapeutics
Start price
Target price
Perf. (%)
€16.30
09.05.25
09.05.25
€38.34
09.05.26
09.05.26
74.29%
10.05.26
10.05.26
Celldex Therapeutics
Start price
Target price
Perf. (%)
€18.40
20.03.25
20.03.25
€42.18
20.03.26
20.03.26
42.39%
21.03.26
21.03.26

